Skip to content

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again

      1. EMEA/
      2. Introducing Economist Impact’s white paper: Do no Harm

      Mark Hicken LinkedIn post

      Introducing Economist Impact’s white paper: Do no Harm

      According to the World Health Organization, climate change is the single biggest health threat facing humanity[1]. The evidence is clear: more and more, the accelerating effects of climate change are affecting people’s health and wellbeing.

      In such a context, I’m encouraged by this latest Economist Impact report, sponsored by Johnson & Johnson - Do no harm: Healthcare professionals address sustainability and climate change.[2] The report explores the intersection of climate change and healthcare systems in Europe (France, Germany and the UK), and looks at how healthcare professionals (HCPs) are responding to climate crisis and improving their systems’ sustainability.

      The findings show that while HCPs want to educate patients about climate change, they first need more education themselves – 74% of HCPs feel they have not been supported in gaining carbon and green literacy skills.[2] Also, 78% of HCPs believe clinical pathways need to be reassessed with sustainability in mind.[2] It’s clear that making healthcare systems more sustainable and reducing our greenhouse gas emissions is now key, when it comes to reaching national net-zero goals and safeguarding the wellbeing of populations.[2]

      At Johnson & Johnson, we know that human health and environmental health are fundamentally linked – healthy people need a healthy planet. And we’re convinced that we can have both. We’re relentlessly driving progress in reducing our emissions to protect environmental health. The climate emergency is a global health challenge of the greatest scale and it’s clear that we all must do more to make our sector more sustainable.

      To read the report, click here. To learn more about Johnson & Johnson’s global sustainability goals visit our site here.

      References

      [1]https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health [Last accessed April 2022]

      [2] Economist Impact Do no harm: healthcare professions address sustainability and climate change, September 2022

      Mark Hicken
      Mark Hicken
      Mark Hicken
      Mark Hicken is Vice President of Strategy for Europe, Middle East and Africa (EMEA) at Janssen. Mark leads a cross-functional team that drives Janssen’s continued growth across the region, in close collaboration with the local operating companies. He focuses on maintaining Janssen’s competitive edge by setting a shared direction across multiple functions, helping Janssen’s people realise their full potential, and resourcing them to deliver for patients across EMEA. Prior to this role, Mark led Janssen global strategy for Neuroscience where he oversaw the preparation and launch of new products and refreshed Janssen’s approach in this therapy area, broadening its footprint beyond psychiatry into neurological disorders. Beginning his career with Janssen in 1998 as a sales representative, Mark worked up through the organisation to become Managing Director for Janssen UK & Ireland from 2014 to 2019. During his tenure, he grew the UK business significantly and was a board member of the Association of British Pharmaceutical Industry (ABPI) and Vice-chair of the American Pharma Group. Mark holds a Postgraduate Diploma in Health Promotion from Manchester University and a BA (Hons) Sport & Recreation Studies from Staffordshire University